Gabriella Maria Squeo

Dr. Gabriella Maria Squeo


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2018 in Human Molecular Genetics
Verified
Journal Article
Closed access
PDF file
DCDario Cocciadiferro
Dario Cocciadiferro
BABartolomeo Augello
Bartolomeo Augello
PNPasquelena De Nittis
Pasquelena De Nittis
JZJiyuan Zhang
Jiyuan Zhang
BMBarbara Mandriani
Barbara Mandriani
Giuseppe MerlaGiuseppe Merla
Giuseppe Merla
Kabuki syndrome is a rare autosomal dominant condition characterized by facial features, various organs malformations, postnatal growth deficiency and intellectual disability. The discovery of frequent germline mutations in the histone methyltransferase KMT2D and the demethylase KDM6A revealed a causative role for histone modifiers in this disease. However, the role of missense mutations has remained unexplored. Here, we expanded the mutation spectrum of KMT2D and KDM6A in KS by identifying 37 new KMT2D sequence variants. Moreover, we functionally dissected 14 KMT2D missense variants, by investigating their impact on the protein enzymatic activity and the binding to members of the WRAD complex. We demonstrate impaired H3K4 methyltransferase activity in 9 of the 14 mutant alleles and show that this reduced activity is due in part to disruption of protein complex formation. These findings have relevant implications for diagnostic and counseling purposes in this disease.

1 June 2018 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
CFCarmela Fusco
Carmela Fusco
BMBarbara Mandriani
Barbara Mandriani
MRMartina Di Rienzo
Martina Di Rienzo
LMLucia Micale
Lucia Micale
NMNatascia Malerba
Natascia Malerba
Giuseppe MerlaGiuseppe Merla
Giuseppe Merla

26 March 2020 in Genes
Verified
Journal Article
Open access
PDF file
FCFlavia Cerrato
Flavia Cerrato
ASAngela Sparago
Angela Sparago
FAFrancesca Ariani
Francesca Ariani
FBFulvia Brugnoletti
Fulvia Brugnoletti
LCLUCIANO CALZARI
LUCIANO CALZARI
ARAndrea Riccio
Andrea Riccio
DNA methylation in the human genome is largely programmed and shaped by transcription factor binding and interaction between DNA methyltransferases and histone marks during gamete and embryo development. Normal methylation profiles can be modified at single or multiple loci, more frequently as consequences of genetic variants acting in cis or in trans, or in some cases stochastically or through interaction with environmental factors. For many developmental disorders, specific methylation patterns or signatures can be detected in blood DNA. The recent use of high-throughput assays investigating the whole genome has largely increased the number of diseases for which DNA methylation analysis provides information for their diagnosis. Here, we review the methylation abnormalities that have been associated with mono/oligogenic diseases, their relationship with genotype and phenotype and relevance for diagnosis, as well as the limitations in their use and interpretation of results.

Verified
Journal Article
Open access
PDF file
KRKathleen Rooney
Kathleen Rooney
MLMichael A. Levy
Michael A. Levy
SHSadegheh Haghshenas
Sadegheh Haghshenas
JKJennifer Kerkhof
Jennifer Kerkhof
DRDaniela Rogaia
Daniela Rogaia
PPPaolo Prontera
Paolo Prontera
The 22q11.2 deletion syndrome (22q11.2DS) is the most common genomic disorder in humans and is the result of a recurrent 1.5 to 2.5 Mb deletion, encompassing approximately 20–40 genes, respectively. The clinical presentation of the typical deletion includes: Velocardiofacial, Di George, Opitz G/BBB and Conotruncalanomaly face syndromes. Atypical deletions (proximal, distal or nested) are rare and characterized mainly by normal phenotype or mild intellectual disability and variable clinical features. The pathogenetic mechanisms underlying this disorder are not completely understood. Because the 22q11.2 region harbours genes coding for transcriptional factors and chromatin remodelers, in this study, we performed analysis of genome-wide DNA methylation of peripheral blood from 49 patients with 22q11.2DS using the Illumina Infinium Methylation EPIC bead chip arrays. This cohort comprises 43 typical, 2 proximal and 4 distal deletions. We demonstrated the evidence of a unique and highly specific episignature in all typical and proximal 22q11.2DS. The sensitivity and specificity of this signature was further confirmed by comparing it to over 1500 patients with other neurodevelopmental disorders with known episignatures. Mapping the 22q11.2DS DNA methylation episignature provides both novel insights into the molecular pathogenesis of this disorder and an effective tool in the molecular diagnosis of 22q11.2DS.

7 July 2021 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
FCFrancesca Di Candia
Francesca Di Candia
PFPaolo Fontana
Paolo Fontana
PPPamela Paglia
Pamela Paglia
MFMARIATERESA FALCO
MARIATERESA FALCO
CRCarmen Rosano
Carmen Rosano
DMDaniela Melis
Daniela Melis
Kabuki syndrome (KS) is a well-recognized disorder characterized by postnatal growth deficiency, dysmorphic facial features, skeletal anomalies, and intellectual disability. The syndrome is caused by KMT2D gene mutations or less frequently KDM6A gene mutations or deletions. We report a systematic evaluation of KS patients from Campania region of Italy; data were also compared with literature ones. We collected data of 15 subjects (8 males and 7 females with age range 10–26 years; mean age 16.9 years) with confirmed diagnosis of KS, representing the entire cohort of patients from Campania Region. Each patient performed biochemical testing and instrumental investigation. Neuro-intellectual development, cranio-facial dysmorphisms, and multisystem involvement data were collected retrospectively. For each category, type of defects and frequency of the anomalies were analyzed. Our observation shows that KS patients from Campania region have some particular and previously underscored, neurological and immunological findings. We found high prevalence of EEG’s abnormalities (43%) and MRI brain abnormalities (60%). Microcephaly resulted more common in our series (33%), if compared with major cohorts described in literature. Biochemical features of immunodeficiency and autoimmune diseases including thyroid autoimmunity, polyserositis, and vitiligo were observed with high prevalence (54.5%). Low immunoglobulins levels were a frequent finding. Lymphocyte class investigation showed significantly reduced CD8 levels in one patient.Conclusions: These data confirm great heterogeneity of clinical manifestations in KS and suggest to introduce further clinical diagnostic criteria in order to perform a correct and precocious diagnosis. What is Known• Kabuki syndrome is characterized by growth deficiency, dysmorphic facial features, skeletal anomalies, and intellectual disability• Immune dysfunction is a common finding but autoimmune diseases are rarely seen• Neurological features are common What is New• Some particular facial features could help gestalt diagnosis (hypertelorism, broad nasal bridge, micrognathia, tooth agenesis, cutaneous haemangiomas and strabismus)• Higher prevalence of autoimmune disorders than previously reported• Particular neurological features are present in this cohort (EEG and MRI brain abnormalities)

1 March 2020 in Cancer Letters
Verified
Journal Article
Closed access
SVSantina Venuto
Santina Venuto
LMLaura Monteonofrio
Laura Monteonofrio
FCflora cozzolino
flora cozzolino
Maria MontiMaria Monti
Maria Monti
IAIrene Appolloni
Irene Appolloni
LMLucia Micale
Lucia Micale